It has been reported that counter-activation of AT2R in response to AT1R blockade contributes to anti-inflammatory effects, suggesting that the losartan-induced treatment effects in RA and experimental arthritis models may be attributed to AT2R. This evidence concerns the gene AGTR1 and rheumatoid arthritis.